The Pyrogen Testing Market was valued at USD 1.36 Billion in 2024, and is projected to reach USD 2.49 Billion by 2030, rising at a CAGR of 11.20%. Increasing demand for therapeutic drugs including pharmaceuticals, biopharmaceuticals, and biologics is the major factor that propels the growth of the market during the forecast period. Pyrogen is a toxic molecular substance that causes fever if induced in an animal or human body. Pyrogen testing is used by pharmaceutical, biopharmaceuticals, biotechnology, and medical devices companies to confirm the absence of pyrogen. Thus, the companies use various methods such as LAL, in vitro pyrogen, and rabbit test to ensure the quality of products.
Increasing prevalence of chronic diseases is another foremost factor supporting market growth. The prevalence of chronic diseases is very high in developed countries and is growing at a high pace in developing countries including China and India. Different factors such as unhealthy diet, smoking, alcohol consumption, and lack of exercise lead to the occurrence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases. Hence, there is a growing demand for therapeutic drugs and medical devices for the treatment of such diseases, which in turn is projected to fuel the demand for pyrogen testing to ensure the quality of products including drugs and devices.
Increasing prevalence of chronic diseases is another foremost factor supporting market growth. The prevalence of chronic diseases is very high in developed countries and is growing at a high pace in developing countries including China and India. Different factors such as unhealthy diet, smoking, alcohol consumption, and lack of exercise lead to the occurrence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases. Hence, there is a growing demand for therapeutic drugs and medical devices for the treatment of such diseases, which in turn is projected to fuel the demand for pyrogen testing to ensure the quality of products including drugs and devices.
Pyrogen Testing Market Report Highlights
- Consumables was the largest revenue grossing segment of this market in 2024, owing to the large application of pyrogen testing kits and reagents along with its repetitive purchase.
- Instruments segment accounted for the remarkable share in the market in 2024 and is also expected to showcase significant growth during the forecast period, owing to rising demand for pharmaceutical, biologics, and medical devices for treatment and diagnosis.
- The pharmaceutical and biotechnology companies segment dominated the pyrogen testing market in terms of revenue in 2024, due to the large production of therapeutic drugs and growing investment in R&D by companies for drug development.
- North America is the leading regional market and accounted for the largest revenue share in 2024 primarily due to the existence of a large number of healthcare companies including pharmaceuticals and medical devices in this region.
- The Asia-Pacific region is anticipated to be the fastest-growing market during the study period. The growing prevalence rate of chronic diseases in Asian countries including India and China is a major factor contributing to the expansion of the market in this region.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Test Type
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.2. Segment Definitions
1.2.1. Product
1.2.2. Test Type
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Test type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Test type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Pyrogen Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising demand for therapeutic drugs
3.2.1.2. Growing investment in R&D
3.2.1.3. Increasing prevalence of chronic disease
3.2.2. Market restraint analysis
3.2.2.1. Stringent government regulations
3.3. Pyrogen Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising demand for therapeutic drugs
3.2.1.2. Growing investment in R&D
3.2.1.3. Increasing prevalence of chronic disease
3.2.2. Market restraint analysis
3.2.2.1. Stringent government regulations
3.3. Pyrogen Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis
Chapter 4. Pyrogen Testing Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Pyrogen Testing Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
4.4.1. Consumables
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Instruments
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Services
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.2. Segment Dashboard
4.3. Global Pyrogen Testing Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
4.4.1. Consumables
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Instruments
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Services
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Pyrogen Testing Market: Test Type Estimates & Trend Analysis
5.1. Test Type Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Pyrogen Testing Market by Test Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
5.4.1. LAL test
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2. Chromogenic test
5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
5.4.1.3. Turbidimetric test
5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
5.4.1.4. Gel clot test
5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
5.4.2. in vitro pyrogen test
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
5.4.2.2. Recombinant Factor C (rFC) testing
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
5.4.2.3. Monocyte Activation Test (MAT)
5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
5.4.3. Rabbit test
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
5.2. Segment Dashboard
5.3. Global Pyrogen Testing Market by Test Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
5.4.1. LAL test
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2. Chromogenic test
5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
5.4.1.3. Turbidimetric test
5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
5.4.1.4. Gel clot test
5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
5.4.2. in vitro pyrogen test
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
5.4.2.2. Recombinant Factor C (rFC) testing
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
5.4.2.3. Monocyte Activation Test (MAT)
5.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
5.4.3. Rabbit test
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)(Number of tests in thousands)
Chapter 6. Pyrogen Testing Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Global Pyrogen Testing Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
6.4.1. Pharmaceutical & biotechnology companies
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Medical devices companies
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.2. Segment Dashboard
6.3. Global Pyrogen Testing Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for The following
6.4.1. Pharmaceutical & biotechnology companies
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Medical devices companies
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Pyrogen Testing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) (Number of Tests by Test Type in thousands)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2024
8.4. Company Profiles
8.4.1. Charles River Laboratories
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Novo Nordisk
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Merck KGaA
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. GenScript
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. bioMérieux SA
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Lonza
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Thermo Fisher Scientific, Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Seikagaku Biobusiness Corporation
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. FUJIFILM Wako Chemicals U.S.A. Corporation (Pyrostar)
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. MiCAN Technologies Inc.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2024
8.4. Company Profiles
8.4.1. Charles River Laboratories
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Novo Nordisk
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Merck KGaA
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. GenScript
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. bioMérieux SA
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Lonza
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Thermo Fisher Scientific, Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Seikagaku Biobusiness Corporation
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. FUJIFILM Wako Chemicals U.S.A. Corporation (Pyrostar)
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. MiCAN Technologies Inc.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America pyrogen testing market, by region, 2018-2030 (USD Million)
Table 3 North America pyrogen testing market, by product, 2018-2030 (USD Million)
Table 4 North America pyrogen testing market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 5 North America LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 6 North America in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 7 North America pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 8 U.S. pyrogen testing market, by product, 2018-2030 (USD Million)
Table 9 U.S. pyrogen testing market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 10 U.S. LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 11 U.S. in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 12 U.S. pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 13 Canada pyrogen testing market, by product, 2018-2030 (USD Million)
Table 14 Canada pyrogen testing market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 15 Canada LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 16 Canada in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 17 Canada pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 18 Mexico pyrogen testing market, by product, 2018-2030 (USD Million)
Table 19 Mexico pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 20 Mexico LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 21 Mexico in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 22 Mexico pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 23 Europe pyrogen testing market, by region, 2018-2030 (USD Million)
Table 24 Europe pyrogen testing market, by product, 2018-2030 (USD Million)
Table 25 Europe pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 26 Europe LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 27 Europe in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 28 Europe pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 29 Germany pyrogen testing market, by product, 2018-2030 (USD Million)
Table 30 Germany pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 31 Germany LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 32 Germany in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 33 Germany pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 34 UK pyrogen testing market, by product, 2018-2030 (USD Million)
Table 35 UK pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 36 UK LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 37 UK in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 38 UK pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 39 France pyrogen testing market, by product, 2018-2030 (USD Million)
Table 40 France pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 41 France LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 42 France in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 43 France pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 44 Italy pyrogen testing market, by product, 2018-2030 (USD Million)
Table 45 Italy pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 46 Italy LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 47 Italy in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 48 Italy pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 49 Spain pyrogen testing market, by product, 2018-2030 (USD Million)
Table 50 Spain pyrogen testing market, by test type, Number of Tests in Thousands) 2018-2030
Table 51 Spain LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 52 Spain in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 53 Spain pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 54 Denmark pyrogen testing market, by product, 2018-2030 (USD Million)
Table 55 Denmark pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 56 Denmark LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 57 Denmark in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 58 Denmark pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 59 Sweden pyrogen testing market, by product, 2018-2030 (USD Million)
Table 60 Sweden pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 61 Sweden LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 62 Sweden in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 63 Sweden pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 64 Norway pyrogen testing market, by product, 2018-2030 (USD Million)
Table 65 Norway pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 66 Norway LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 67 Norway in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 68 Norway pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 69 Asia Pacific pyrogen testing market, by region, 2018-2030 (USD Million)
Table 70 Asia Pacific pyrogen testing market, by product, 2018-2030 (USD Million)
Table 71 Asia Pacific pyrogen testing market, by test type, Number of Tests in Thousands) 2018-2030
Table 72 Asia Pacific LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 73 Asia Pacific in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 74 Asia Pacific pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 75 China pyrogen testing market, by product, 2018-2030 (USD Million)
Table 76 China pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 77 China LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 78 China in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 79 China pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 80 Japan pyrogen testing market, by product, 2018-2030 (USD Million)
Table 81 Japan pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 82 Japan LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 83 Japan in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 84 Japan pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 85 India pyrogen testing market, by product, 2018-2030 (USD Million)
Table 86 India pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 87 India LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 88 India in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 89 India pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 90 South Korea pyrogen testing market, by product, 2018-2030 (USD Million)
Table 91 South Korea pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 92 South Korea LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 93 South Korea in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 94 South Korea pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 95 Australia pyrogen testing market, by product, 2018-2030 (USD Million)
Table 96 Australia pyrogen testing market, by test type, Number of Tests in Thousands) 2018-2030
Table 97 Australia LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 98 Australia in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 99 Australia pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 100 Thailand pyrogen testing market, by product, 2018-2030 (USD Million)
Table 101 Thailand pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 102 Thailand LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 103 Thailand in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 104 Thailand pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 105 Latin America pyrogen testing market, by product, 2018-2030 (USD Million)
Table 106 Latin America pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 107 Latin America LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 108 Latin America in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 109 Latin America pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 110 Brazil pyrogen testing market, by product, 2018-2030 (USD Million)
Table 111 Brazil pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 112 Brazil LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 113 Brazil in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 114 Brazil pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 115 Argentina pyrogen testing market, by product, 2018-2030 (USD Million)
Table 116 Argentina pyrogen testing market, by test type, Number of Tests in Thousands) 2018-2030
Table 117 Argentina LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 118 Argentina in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 119 Argentina pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 120 MEA pyrogen testing market, by region, 2018-2030 (USD Million)
Table 121 MEA pyrogen testing market, by product, 2018-2030 (USD Million)
Table 122 MEA pyrogen testing market, by test type, (USD Million Number of Tests in Thousands) 2018-2030
Table 123 MEA LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 124 MEA in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 125 MEA pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 126 South Africa pyrogen testing market, by product, 2018-2030 (USD Million)
Table 127 South Africa pyrogen testing market, by test type, Number of Tests in Thousands) 2018-2030
Table 128 South Africa LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 129 South Africa in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 130 South Africa pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 131 Saudi Arabia pyrogen testing market, by product, 2018-2030 (USD Million)
Table 132 Saudi Arabia pyrogen testing market, by test type, Number of Tests in Thousands) 2018-2030
Table 133 Saudi Arabia LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 134 Saudi Arabia in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 135 Saudi Arabia pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 136 UAE pyrogen testing market, by product, 2018-2030 (USD Million)
Table 137 UAE pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 138 UAE LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 139 UAE in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 140 UAE pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 141 Kuwait pyrogen testing market, by product, 2018-2030 (USD Million)
Table 142 Kuwait pyrogen testing market, by test type, 2018-2030 (Number of Tests in Thousands)
Table 143 Kuwait LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 144 Kuwait in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 145 Kuwait pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 2 North America pyrogen testing market, by region, 2018-2030 (USD Million)
Table 3 North America pyrogen testing market, by product, 2018-2030 (USD Million)
Table 4 North America pyrogen testing market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 5 North America LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 6 North America in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 7 North America pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 8 U.S. pyrogen testing market, by product, 2018-2030 (USD Million)
Table 9 U.S. pyrogen testing market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 10 U.S. LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 11 U.S. in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 12 U.S. pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 13 Canada pyrogen testing market, by product, 2018-2030 (USD Million)
Table 14 Canada pyrogen testing market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 15 Canada LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 16 Canada in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 17 Canada pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 18 Mexico pyrogen testing market, by product, 2018-2030 (USD Million)
Table 19 Mexico pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 20 Mexico LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 21 Mexico in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 22 Mexico pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 23 Europe pyrogen testing market, by region, 2018-2030 (USD Million)
Table 24 Europe pyrogen testing market, by product, 2018-2030 (USD Million)
Table 25 Europe pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 26 Europe LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 27 Europe in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 28 Europe pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 29 Germany pyrogen testing market, by product, 2018-2030 (USD Million)
Table 30 Germany pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 31 Germany LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 32 Germany in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 33 Germany pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 34 UK pyrogen testing market, by product, 2018-2030 (USD Million)
Table 35 UK pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 36 UK LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 37 UK in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 38 UK pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 39 France pyrogen testing market, by product, 2018-2030 (USD Million)
Table 40 France pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 41 France LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 42 France in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 43 France pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 44 Italy pyrogen testing market, by product, 2018-2030 (USD Million)
Table 45 Italy pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 46 Italy LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 47 Italy in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 48 Italy pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 49 Spain pyrogen testing market, by product, 2018-2030 (USD Million)
Table 50 Spain pyrogen testing market, by test type, Number of Tests in Thousands) 2018-2030
Table 51 Spain LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 52 Spain in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 53 Spain pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 54 Denmark pyrogen testing market, by product, 2018-2030 (USD Million)
Table 55 Denmark pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 56 Denmark LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 57 Denmark in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 58 Denmark pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 59 Sweden pyrogen testing market, by product, 2018-2030 (USD Million)
Table 60 Sweden pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 61 Sweden LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 62 Sweden in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 63 Sweden pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 64 Norway pyrogen testing market, by product, 2018-2030 (USD Million)
Table 65 Norway pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 66 Norway LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 67 Norway in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 68 Norway pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 69 Asia Pacific pyrogen testing market, by region, 2018-2030 (USD Million)
Table 70 Asia Pacific pyrogen testing market, by product, 2018-2030 (USD Million)
Table 71 Asia Pacific pyrogen testing market, by test type, Number of Tests in Thousands) 2018-2030
Table 72 Asia Pacific LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 73 Asia Pacific in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 74 Asia Pacific pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 75 China pyrogen testing market, by product, 2018-2030 (USD Million)
Table 76 China pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 77 China LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 78 China in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 79 China pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 80 Japan pyrogen testing market, by product, 2018-2030 (USD Million)
Table 81 Japan pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 82 Japan LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 83 Japan in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 84 Japan pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 85 India pyrogen testing market, by product, 2018-2030 (USD Million)
Table 86 India pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 87 India LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 88 India in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 89 India pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 90 South Korea pyrogen testing market, by product, 2018-2030 (USD Million)
Table 91 South Korea pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 92 South Korea LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 93 South Korea in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 94 South Korea pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 95 Australia pyrogen testing market, by product, 2018-2030 (USD Million)
Table 96 Australia pyrogen testing market, by test type, Number of Tests in Thousands) 2018-2030
Table 97 Australia LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 98 Australia in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 99 Australia pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 100 Thailand pyrogen testing market, by product, 2018-2030 (USD Million)
Table 101 Thailand pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 102 Thailand LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 103 Thailand in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 104 Thailand pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 105 Latin America pyrogen testing market, by product, 2018-2030 (USD Million)
Table 106 Latin America pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 107 Latin America LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 108 Latin America in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 109 Latin America pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 110 Brazil pyrogen testing market, by product, 2018-2030 (USD Million)
Table 111 Brazil pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 112 Brazil LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 113 Brazil in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 114 Brazil pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 115 Argentina pyrogen testing market, by product, 2018-2030 (USD Million)
Table 116 Argentina pyrogen testing market, by test type, Number of Tests in Thousands) 2018-2030
Table 117 Argentina LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 118 Argentina in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 119 Argentina pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 120 MEA pyrogen testing market, by region, 2018-2030 (USD Million)
Table 121 MEA pyrogen testing market, by product, 2018-2030 (USD Million)
Table 122 MEA pyrogen testing market, by test type, (USD Million Number of Tests in Thousands) 2018-2030
Table 123 MEA LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 124 MEA in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 125 MEA pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 126 South Africa pyrogen testing market, by product, 2018-2030 (USD Million)
Table 127 South Africa pyrogen testing market, by test type, Number of Tests in Thousands) 2018-2030
Table 128 South Africa LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 129 South Africa in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 130 South Africa pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 131 Saudi Arabia pyrogen testing market, by product, 2018-2030 (USD Million)
Table 132 Saudi Arabia pyrogen testing market, by test type, Number of Tests in Thousands) 2018-2030
Table 133 Saudi Arabia LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 134 Saudi Arabia in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 135 Saudi Arabia pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 136 UAE pyrogen testing market, by product, 2018-2030 (USD Million)
Table 137 UAE pyrogen testing market, by test type, (USD Million) Number of Tests in Thousands) 2018-2030
Table 138 UAE LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 139 UAE in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 140 UAE pyrogen testing market, by end use, 2018-2030 (USD Million)
Table 141 Kuwait pyrogen testing market, by product, 2018-2030 (USD Million)
Table 142 Kuwait pyrogen testing market, by test type, 2018-2030 (Number of Tests in Thousands)
Table 143 Kuwait LAL test market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 144 Kuwait in vitro pyrogen testing market, by type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 145 Kuwait pyrogen testing market, by end use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Pyrogen testing market: market outlook
Figure 14 Pyrogen testing competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Penetration and growth prospect mapping
Figure 18 Industry value chain analysis
Figure 19 Pyrogen testing market driver impact
Figure 20 Pyrogen testing market restraint impact
Figure 21 Pyrogen testing market strategic initiatives analysis
Figure 22 Pyrogen testing market: Product movement analysis
Figure 23 Pyrogen testing market: Product outlook and key takeaways
Figure 24 Consumables market estimates and forecast, 2018-2030
Figure 25 Instruments estimates and forecast, 2018-2030
Figure 26 Services market estimates and forecast, 2018-2030
Figure 27 Pyrogen testing market: Test type movement analysis
Figure 28 Pyrogen testing market: Test type outlook and key takeaways
Figure 29 LAL test market estimates and forecast, 2018-2030
Figure 30 Chromogenic test estimates and forecast, 2018-2030
Figure 31 Turbidimetric test market estimates and forecast, 2018-2030
Figure 32 Gel clot test market estimates and forecast, 2018-2030
Figure 33 In vitro pyrogen test estimates and forecast, 2018-2030
Figure 34 Monocyte Activation Test (MAT) market estimates and forecast, 2018-2030
Figure 35 Recombinant Factor C (rFC) testing market estimates and forecast, 2018-2030
Figure 36 Rabbit test market estimates and forecast, 2018-2030
Figure 37 Pyrogen testing Market: End use movement Analysis
Figure 38 Pyrogen testing market: End use outlook and key takeaways
Figure 39 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018-2030
Figure 40 Medical devices companies market estimates and forecasts,2018-2030
Figure 41 Others market estimates and forecasts,2018-2030
Figure 42 Global pyrogen testing market: Regional movement analysis
Figure 43 Global pyrogen testing market: Regional outlook and key takeaways
Figure 44 Global pyrogen testing market share and leading players
Figure 45 North America market share and leading players
Figure 46 Europe market share and leading players
Figure 47 Asia Pacific market share and leading players
Figure 48 Latin America market share and leading players
Figure 49 Middle East & Africa market share and leading players
Figure 50 North America, by country
Figure 51 North America market estimates and forecasts, 2018-2030
Figure 52 U.S. market estimates and forecasts, 2018-2030
Figure 53 Canada market estimates and forecasts, 2018-2030
Figure 54 Mexico market estimates and forecasts, 2018-2030
Figure 55 Europe market estimates and forecasts, 2018-2030
Figure 56 UK market estimates and forecasts, 2018-2030
Figure 57 Germany market estimates and forecasts, 2018-2030
Figure 58 France market estimates and forecasts, 2018-2030
Figure 59 Italy market estimates and forecasts, 2018-2030
Figure 60 Spain market estimates and forecasts, 2018-2030
Figure 61 Denmark market estimates and forecasts, 2018-2030
Figure 62 Sweden market estimates and forecasts, 2018-2030
Figure 63 Norway market estimates and forecasts, 2018-2030
Figure 64 Asia Pacific market estimates and forecasts, 2018-2030
Figure 65 China market estimates and forecasts, 2018-2030
Figure 66 Japan market estimates and forecasts, 2018-2030
Figure 67 India market estimates and forecasts, 2018-2030
Figure 68 Thailand market estimates and forecasts, 2018-2030
Figure 69 South Korea market estimates and forecasts, 2018-2030
Figure 70 Australia market estimates and forecasts, 2018-2030
Figure 71 Latin America market estimates and forecasts, 2018-2030
Figure 72 Brazil market estimates and forecasts, 2018-2030
Figure 73 Argentina market estimates and forecasts, 2018-2030
Figure 74 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 75 South Africa market estimates and forecasts, 2018-2030
Figure 76 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 77 UAE market estimates and forecasts, 2018-2030
Figure 78 Kuwait market estimates and forecasts, 2018-2030
Figure 79 Market share of key market players - Pyrogen testing market
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Pyrogen testing market: market outlook
Figure 14 Pyrogen testing competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Penetration and growth prospect mapping
Figure 18 Industry value chain analysis
Figure 19 Pyrogen testing market driver impact
Figure 20 Pyrogen testing market restraint impact
Figure 21 Pyrogen testing market strategic initiatives analysis
Figure 22 Pyrogen testing market: Product movement analysis
Figure 23 Pyrogen testing market: Product outlook and key takeaways
Figure 24 Consumables market estimates and forecast, 2018-2030
Figure 25 Instruments estimates and forecast, 2018-2030
Figure 26 Services market estimates and forecast, 2018-2030
Figure 27 Pyrogen testing market: Test type movement analysis
Figure 28 Pyrogen testing market: Test type outlook and key takeaways
Figure 29 LAL test market estimates and forecast, 2018-2030
Figure 30 Chromogenic test estimates and forecast, 2018-2030
Figure 31 Turbidimetric test market estimates and forecast, 2018-2030
Figure 32 Gel clot test market estimates and forecast, 2018-2030
Figure 33 In vitro pyrogen test estimates and forecast, 2018-2030
Figure 34 Monocyte Activation Test (MAT) market estimates and forecast, 2018-2030
Figure 35 Recombinant Factor C (rFC) testing market estimates and forecast, 2018-2030
Figure 36 Rabbit test market estimates and forecast, 2018-2030
Figure 37 Pyrogen testing Market: End use movement Analysis
Figure 38 Pyrogen testing market: End use outlook and key takeaways
Figure 39 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018-2030
Figure 40 Medical devices companies market estimates and forecasts,2018-2030
Figure 41 Others market estimates and forecasts,2018-2030
Figure 42 Global pyrogen testing market: Regional movement analysis
Figure 43 Global pyrogen testing market: Regional outlook and key takeaways
Figure 44 Global pyrogen testing market share and leading players
Figure 45 North America market share and leading players
Figure 46 Europe market share and leading players
Figure 47 Asia Pacific market share and leading players
Figure 48 Latin America market share and leading players
Figure 49 Middle East & Africa market share and leading players
Figure 50 North America, by country
Figure 51 North America market estimates and forecasts, 2018-2030
Figure 52 U.S. market estimates and forecasts, 2018-2030
Figure 53 Canada market estimates and forecasts, 2018-2030
Figure 54 Mexico market estimates and forecasts, 2018-2030
Figure 55 Europe market estimates and forecasts, 2018-2030
Figure 56 UK market estimates and forecasts, 2018-2030
Figure 57 Germany market estimates and forecasts, 2018-2030
Figure 58 France market estimates and forecasts, 2018-2030
Figure 59 Italy market estimates and forecasts, 2018-2030
Figure 60 Spain market estimates and forecasts, 2018-2030
Figure 61 Denmark market estimates and forecasts, 2018-2030
Figure 62 Sweden market estimates and forecasts, 2018-2030
Figure 63 Norway market estimates and forecasts, 2018-2030
Figure 64 Asia Pacific market estimates and forecasts, 2018-2030
Figure 65 China market estimates and forecasts, 2018-2030
Figure 66 Japan market estimates and forecasts, 2018-2030
Figure 67 India market estimates and forecasts, 2018-2030
Figure 68 Thailand market estimates and forecasts, 2018-2030
Figure 69 South Korea market estimates and forecasts, 2018-2030
Figure 70 Australia market estimates and forecasts, 2018-2030
Figure 71 Latin America market estimates and forecasts, 2018-2030
Figure 72 Brazil market estimates and forecasts, 2018-2030
Figure 73 Argentina market estimates and forecasts, 2018-2030
Figure 74 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 75 South Africa market estimates and forecasts, 2018-2030
Figure 76 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 77 UAE market estimates and forecasts, 2018-2030
Figure 78 Kuwait market estimates and forecasts, 2018-2030
Figure 79 Market share of key market players - Pyrogen testing market
Companies Mentioned
The companies profiled in this Pyrogen Testing market report include:- Charles River Laboratories
- Novo Nordisk
- Merck KGaA
- GenScript
- bioMérieux SA
- Lonza Group
- Thermo Fisher Scientific, Inc.
- Seikagaku Biobusiness Corporation
- FUJIFILM Wako Chemicals U.S.A. Corporation (Pyrostar)
- MiCAN Technologies Inc.
Methodology
LOADING...
